Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe UK EUR

Fresenius SE & Co. KGaA (FRED.XC)

39.32
0.00
(0.00%)
At close: April 23 at 3:06:47 PM GMT+1
Loading Chart for FRED.XC
  • Previous Close 39.32
  • Open 39.47
  • Bid --
  • Ask 39.32 x --
  • Day's Range 39.32 - 39.32
  • 52 Week Range 27.30 - 40.01
  • Volume 2,403
  • Avg. Volume 161
  • Market Cap (intraday) 22.445B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) 24.57
  • EPS (TTM) 1.60
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield 1.00 (2.54%)
  • Ex-Dividend Date May 27, 2025
  • 1y Target Est --

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

www.fresenius.com

176,486

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FRED.XC

View More

Performance Overview: FRED.XC

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

FRED.XC
17.41%
DAX P (^GDAXI)
11.72%

1-Year Return

FRED.XC
43.14%
DAX P (^GDAXI)
24.14%

3-Year Return

FRED.XC
25.11%
DAX P (^GDAXI)
59.74%

5-Year Return

FRED.XC
15.45%
DAX P (^GDAXI)
115.19%

Compare To: FRED.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FRED.XC

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    22.45B

  • Enterprise Value

    33.98B

  • Trailing P/E

    24.57

  • Forward P/E

    11.51

  • PEG Ratio (5yr expected)

    0.28

  • Price/Sales (ttm)

    1.01

  • Price/Book (mrq)

    1.13

  • Enterprise Value/Revenue

    1.56

  • Enterprise Value/EBITDA

    10.82

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.16%

  • Return on Assets (ttm)

    2.51%

  • Return on Equity (ttm)

    4.34%

  • Revenue (ttm)

    21.83B

  • Net Income Avi to Common (ttm)

    1.04B

  • Diluted EPS (ttm)

    1.60

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.29B

  • Total Debt/Equity (mrq)

    66.91%

  • Levered Free Cash Flow (ttm)

    1.37B

Research Analysis: FRED.XC

View More

Company Insights: FRED.XC

Research Reports: FRED.XC

View More